215 related articles for article (PubMed ID: 34713106)
41. Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock - rationale and design of a multicenter randomized controlled superiority trial.
Roggeveen LF; Fleuren LM; Guo T; Thoral P; de Grooth HJ; Swart EL; Klausch TLT; van der Voort PHJ; Girbes ARJ; Bosman RJ; Elbers PWG
Trials; 2019 Dec; 20(1):745. PubMed ID: 31852491
[TBL] [Abstract][Full Text] [Related]
42. Retrograde intramedullary nail fixation compared with fixed-angle plate fixation for fracture of the distal femur: the TrAFFix feasibility RCT.
Griffin XL; Costa ML; Phelps E; Parsons N; Dritsaki M; Png ME; Achten J; Tutton E; Lerner R; McGibbon A; Baird J
Health Technol Assess; 2019 Sep; 23(51):1-132. PubMed ID: 31549959
[TBL] [Abstract][Full Text] [Related]
43. Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.
Poolman M; Roberts J; Wright S; Hendry A; Goulden N; Holmes EA; Byrne A; Perkins P; Hoare Z; Nelson A; Hiscock J; Hughes D; O'Connor J; Foster B; Reymond L; Healy S; Lewis P; Wee B; Johnstone R; Roberts R; Parkinson A; Roberts S; Wilkinson C
Health Technol Assess; 2020 May; 24(25):1-150. PubMed ID: 32484432
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of oral administration of cystine and theanine in patients with colorectal cancer undergoing capecitabine-based adjuvant chemotherapy after surgery: study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled, phase II trial.
Hamaguchi R; Tsuchiya T; Miyata G; Sato T; Takahashi K; Ariyoshi K; Oyamada S; Iwase S
BMJ Open; 2018 Jul; 8(7):e021442. PubMed ID: 30030317
[TBL] [Abstract][Full Text] [Related]
45. Guided internet-administered self-help to reduce symptoms of anxiety and depression among adolescents and young adults diagnosed with cancer during adolescence (U-CARE: YoungCan): a study protocol for a feasibility trial.
Ander M; Wikman A; Ljótsson B; Grönqvist H; Ljungman G; Woodford J; Lindahl Norberg A; von Essen L
BMJ Open; 2017 Jan; 7(1):e013906. PubMed ID: 28132011
[TBL] [Abstract][Full Text] [Related]
46. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
47. Acupuncture for cancer pain: protocol for a pilot pragmatic randomised controlled trial.
He Y; May BH; Zhang AL; Guo X; Liu Y; Qu Y; Chang X; Lu CJ; Xue CC; Zhang H
BMJ Open; 2019 Jul; 9(7):e025564. PubMed ID: 31289059
[TBL] [Abstract][Full Text] [Related]
48. A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol.
Engineer R; Patkar S; Lewis SC; Sharma AD; Shetty N; Ostwal V; Ramaswamy A; Chopra S; Agrawal A; Patil P; Mehta S; Goel M
BMJ Open; 2019 Jun; 9(6):e028147. PubMed ID: 31253621
[TBL] [Abstract][Full Text] [Related]
49. eHealth-based intervention to increase physical activity levels in people with cancer: protocol of a feasibility trial in an Irish acute hospital setting.
Haberlin C; Broderick J; Guinan EM; Darker C; Hussey J; O'Donnell DM
BMJ Open; 2019 Mar; 9(3):e024999. PubMed ID: 30852540
[TBL] [Abstract][Full Text] [Related]
50. Protocol for a pilot randomised controlled trial evaluating feasibility and acceptability of cognitive remediation group therapy compared with mutual aid group therapy for people ageing with HIV-associated neurocognitive disorder (HAND) in Toronto, Canada.
Eaton AD; Walmsley SL; Craig SL; Rourke SB; Sota T; McCullagh JW; Fallon BA
BMJ Open; 2019 Oct; 9(10):e033183. PubMed ID: 31676660
[TBL] [Abstract][Full Text] [Related]
51. Physiotherapist-led treatment for femoroacetabular impingement syndrome (the PhysioFIRST study): a protocol for a participant and assessor-blinded randomised controlled trial.
Kemp JL; Johnston RTR; Coburn SL; Jones DM; Schache AG; Mentiplay BF; King MG; Scholes MJ; De Oliveira Silva D; Smith A; McPhail SM; Crossley KM
BMJ Open; 2021 Apr; 11(4):e041742. PubMed ID: 33827828
[TBL] [Abstract][Full Text] [Related]
52. Tailored mHealth intervention for improving treatment adherence for people living with HIV in Iran (HamRaah): protocol for a feasibility study and randomised pilot trial with a nested realist evaluation.
Ameli V; Haberer J; Sabin L; Meinck F; Barlow J; Taj L; Mohraz M
BMJ Open; 2021 Jun; 11(6):e042296. PubMed ID: 34162631
[TBL] [Abstract][Full Text] [Related]
53. Evaluating machine learning-enabled and multimodal data-driven exercise prescriptions for mental health: a randomized controlled trial protocol.
Tan M; Xiao Y; Jing F; Xie Y; Lu S; Xiang M; Ren H
Front Psychiatry; 2024; 15():1352420. PubMed ID: 38287940
[TBL] [Abstract][Full Text] [Related]
54. Evaluating the utility of digital phenotyping to predict health outcomes in schizophrenia: protocol for the HOPE-S observational study.
Abdul Rashid NA; Martanto W; Yang Z; Wang X; Heaukulani C; Vouk N; Buddhika T; Wei Y; Verma S; Tang C; Morris RJT; Lee J
BMJ Open; 2021 Oct; 11(10):e046552. PubMed ID: 34670760
[TBL] [Abstract][Full Text] [Related]
55. Acceptability and feasibility study of patient-specific 'tumouroids' as personalised treatment screening tools: Protocol for prospective tissue and data collection of participants with confirmed or suspected renal cell carcinoma.
Tran MGB; Neves JB; Stamati K; Redondo P; Cope A; Brew-Graves C; Williams NR; Grierson J; Cheema U; Loizidou M; Emberton M
Int J Surg Protoc; 2019; 14():24-29. PubMed ID: 31851732
[TBL] [Abstract][Full Text] [Related]
56. Modified study designs to expand treatment options in personalised oncology: a multistakeholder view.
Le Tourneau C; André F; Helland Å; Mileshkin L; Minnaard W; Schiel A; Taskén K; Thomas DM; Veronese ML; Durán-Pacheco G; Leyens L; Rufibach K; Thomas M; Krämer A
Eur J Cancer; 2023 Nov; 194():113278. PubMed ID: 37820553
[TBL] [Abstract][Full Text] [Related]
57. Characteristics and interpretation of subgroup analyses based on tumour characteristics in randomised trials testing target-specific anticancer drugs: design of a systematic survey.
Schandelmaier S; Schmitt AM; Herbrand AK; Glinz D; Ewald H; Briel M; Guyatt GH; Hemkens LG; Kasenda B
BMJ Open; 2020 May; 10(5):e034565. PubMed ID: 32474426
[TBL] [Abstract][Full Text] [Related]
58. Patient similarity and other artificial intelligence machine learning algorithms in clinical decision aid for shared decision-making in the Prevention of Cardiovascular Toxicity (PACT): a feasibility trial design.
Brown SA; Chung BY; Doshi K; Hamid A; Pederson E; Maddula R; Hanna A; Choudhuri I; Sparapani R; Bagheri Mohamadi Pour M; Zhang J; Kothari AN; Collier P; Caraballo P; Noseworthy P; Arruda-Olson A;
Cardiooncology; 2023 Jan; 9(1):7. PubMed ID: 36691060
[TBL] [Abstract][Full Text] [Related]
59. Artificial Intelligence-Guided Prediction of Dental Doses Before Planning of Radiation Therapy for Oropharyngeal Cancer: Technical Development and Initial Feasibility of Implementation.
Chan JW; Hohenstein N; Carpenter C; Pattison AJ; Morin O; Valdes G; Sanchez CT; Perkins J; Solberg TD; Yom SS
Adv Radiat Oncol; 2022; 7(2):100886. PubMed ID: 35387423
[TBL] [Abstract][Full Text] [Related]
60. At the right dose: personalised (N-of-1) dosing for precision oncology.
Nikanjam M; Kato S; Sicklick JK; Kurzrock R
Eur J Cancer; 2023 Nov; 194():113359. PubMed ID: 37832506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
